advertisement

Oculus

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (114)

Showing records 1 to 25

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Cesar ALA
Journal of Biomedical Materials Research - Part A 2020; 0:
90021 Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma
Kompella UB
Progress in Retinal and Eye Research 2020; 0: 100901
90507 The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
Guo Y
BMC Ophthalmology 2020; 20: 277
90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Han X
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355
90630 Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy
Cuggino JC
Materials science & engineering. C, Materials for biological applications 2021; 118: 111383
90502 The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial
Kasetsuwan N
Clinical Ophthalmology 2020; 14: 2891-2902
90661 Polypeptide and glycosaminoglycan polysaccharide as stabilizing polymers in nanocrystals for a safe ocular hypotensive effect
Donia M
International Journal of Biological Macromolecules 2020; 162: 1699-1710
90627 Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma
Nguyen DD
Acta biomaterialia 2020; 111: 302-315
90459 Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: A 2-year randomized evaluation study
Mohammed I
Clinical and Experimental Ophthalmology 2020; 48: 973-982
89989 Intractable Ocular Diseases and Treatment Progress
Zhang X
AAPS PharmSciTech 2020; 21: 236
90672 Effect of aging on heat transfer, fluid flow and drug transport in anterior human eye: A computational study
Bhandari A
Journal of Controlled Release 2020; 328: 286-303
90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Mietzner R
Pharmaceutics 2020; 12:
90473 Effect of Long-Term Topical Antiglaucoma Medication Use on the Ocular Surface
Awe OO
Nigerian medical journal : journal of the Nigeria Medical Association 2020; 61: 184-188
90252 Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
Gozawa M
BMC Ophthalmology 2020; 20: 244
90627 Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma
Nguyen DD
Acta biomaterialia 2020; 111: 302-315
90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Stack T
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205
90655 Numerical modeling of therapeutic lens drug delivery in the anterior human eye for the treatment of primary open-angle glaucoma
Bhandari A
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine 2020; 234: 942-954
89986 Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment
Kwon S
International Journal of Nanomedicine 2020; 15: 5745-5765
90541 Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties
Ismail A
International Journal of Pharmaceutics 2020; 583: 119402
90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Schnichels S
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260
89876 Bimatoprost Implant: First Approval
Shirley M
Drugs and Aging 2020; 37: 457-462
90570 Nanoscale Drug Delivery Systems for Glaucoma: Experimental and In Silico Advances
Sharma S
Current Topics in Medicinal Chemistry 2021; 21: 115-125
90679 Ocular co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation
Taka E
Pharmaceuticals (Basel, Switzerland) 2020; 13:
90627 Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma
Luo LJ
Acta biomaterialia 2020; 111: 302-315
90252 Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
Takamura Y
BMC Ophthalmology 2020; 20: 244

Issue 21-3

Change Issue


advertisement

WGC-2021